Taft Stettinius & Hollister has been recognized as one of the top five defense firms for ANDA litigation in Lex Machina’s 2017 Hatch-Waxman/ANDA Litigation Report. Taft is listed as fifth on the list of “Top law firms by cases filed 2015-2017Q1 representing defendants,” with 31 cases. The third annual report mines legal analytics to look for trends and insights into pharmaceutical patent litigation.
Taft has one of the premier Hatch-Waxman Litigation practices in the nation, combining several decades of experience among its trial lawyers, Ph.D.-level scientific advisors and staff. Led by Stephen R. Auten, the team has been involved in more than 100 ANDA patent litigations over the years and numerous others relating to 505(b)(2) applications.
“We’re very thankful that our generic drug clients allow us to partner with them in their efforts to bring affordable, high-quality medicines to the U.S. market,” said Auten, chair of Taft’s Pharmaceutical & Life Sciences group.
Excerpt reprinted by permission. Lex Machina - Hatch-Waxman ANDA Litigation Report 2017, Page 11
At Taft Stettinius & Hollister LLP, delivering outstanding legal performance to help clients succeed is what drives and motivates our attorneys every day. Taft has offices in Ann Arbor, Mich.; Chicago, Ill.; Cincinnati, Cleveland, Columbus and Dayton, Ohio; Indianapolis, Ind.; Covington, Ky.; and Phoenix, Ariz. More than 400 attorneys practice across a wide range of industries, in virtually every area of law, including Business and Finance; Litigation; Labor and Employment; Intellectual Property; Business Restructuring, Bankruptcy and Creditor Rights; Environmental; Health and Life Sciences; Private Client Services; Real Estate; and Tax. With a proven track record of experience since 1885, the firm offers breadth and depth of legal expertise coupled with a trusted business perspective to help our clients, big and small, regionally, nationally and internationally, reach their goals.